PTC Therapeutics Inc (PTCT)
25.49
+0.28
(+1.11%)
USD |
NASDAQ |
Apr 25, 16:00
25.50
+0.01
(+0.04%)
After-Hours: 20:00
PTC Therapeutics Net Income (Quarterly): -155.79M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -155.79M |
| September 30, 2023 | -132.97M |
| June 30, 2023 | -198.88M |
| March 31, 2023 | -138.96M |
| December 31, 2022 | -170.89M |
| September 30, 2022 | -109.32M |
| June 30, 2022 | -152.09M |
| March 31, 2022 | -126.73M |
| December 31, 2021 | -143.26M |
| September 30, 2021 | -133.62M |
| June 30, 2021 | -118.37M |
| March 31, 2021 | -128.64M |
| December 31, 2020 | -74.35M |
| September 30, 2020 | -69.69M |
| June 30, 2020 | -181.43M |
| March 31, 2020 | -112.69M |
| December 31, 2019 | -77.68M |
| September 30, 2019 | -60.00M |
| June 30, 2019 | -41.79M |
| March 31, 2019 | -72.11M |
| December 31, 2018 | -48.33M |
| September 30, 2018 | -50.97M |
| June 30, 2018 | -9.52M |
| March 31, 2018 | -19.26M |
| Date | Value |
|---|---|
| December 31, 2017 | 1.27M |
| September 30, 2017 | -33.74M |
| June 30, 2017 | -17.48M |
| March 31, 2017 | -29.06M |
| December 31, 2016 | -26.80M |
| September 30, 2016 | -35.17M |
| June 30, 2016 | -38.91M |
| March 31, 2016 | -41.23M |
| December 31, 2015 | -50.95M |
| September 30, 2015 | -43.22M |
| June 30, 2015 | -38.36M |
| March 31, 2015 | -37.92M |
| December 31, 2014 | -27.27M |
| September 30, 2014 | -27.28M |
| June 30, 2014 | -25.10M |
| March 31, 2014 | -14.10M |
| December 31, 2013 | -17.89M |
| September 30, 2013 | -4.416M |
| June 30, 2013 | -14.59M |
| March 31, 2013 | -14.68M |
| December 31, 2012 | -6.272M |
| September 30, 2012 | -7.297M |
| June 30, 2012 | -6.068M |
| March 31, 2012 | -6.598M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-198.88M
Minimum
Jun 2023
-41.79M
Maximum
Jun 2019
-122.48M
Average
-128.64M
Median
Mar 2021
Net Income (Quarterly) Benchmarks
| Sarepta Therapeutics Inc | 45.66M |
| Catalyst Pharmaceuticals Inc | 34.84M |
| Pfizer Inc | -3.369B |
| Geron Corp | -51.97M |
| Perspective Therapeutics Inc | -24.68M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 307.06M |
| Total Expenses (Quarterly) | 303.94M |
| EPS Diluted (Quarterly) | -2.06 |
| Enterprise Value | 3.174B |
| Gross Profit Margin (Quarterly) | 90.52% |
| Profit Margin (Quarterly) | -50.74% |
| Earnings Yield | -32.80% |
| Normalized Earnings Yield | -21.77 |